AWS
DMK

Atria Wealth Solutions’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Atria Wealth Solutions’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-214
Closed -$8K – 1873
2022
Q2 		$8K Hold
214
– – ﹤0.01% 1624
2022
Q1 		$9K Buy
+214
New +$9.19K ﹤0.01% 1720

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atria Wealth Solutions's DMK Position: Q3 2022 in Review

Atria Wealth Solutions sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2022, closing a stake of 214 shares — an estimated $8K sold.

Atria Wealth Solutions first reported a position in DMK in Q1 2022 and held it in 2 quarters. The position peaked at $9K in Q1 2022. 43 funds tracked by Wall St. Rank hold DMK as of Q3 2022.

  • Atria Wealth Solutions reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2022 after selling out during the quarter.
  • Atria Wealth Solutions sold 214 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2022, an estimated $8K.
  • Atria Wealth Solutions first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2022 and held it in 2 quarters.
  • Atria Wealth Solutions's DMK Pharmaceuticals Corporation Common Stock position peaked at $9K in Q1 2022.
  • 43 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2022.

Based on Atria Wealth Solutions's 13F filing for Q3 2022, filed 14 Nov 2022.